Spire Wealth Management Organogenesis Holdings Inc. Transaction History

Spire Wealth Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$4.74 - $8.15 $114,314 - $196,553	-24,117 Closed	0 $0
Q1 2022 Apr 18, 2022	BUY	$6.47 - $9.57 $80,771 - $119,471	12,484 Added 107.32%	24,117 $184,000
Q4 2021 Jan 14, 2022	BUY	$9.02 - $13.5 $2,706 - $4,050	300 Added 2.65%	11,633 $107,000
Q3 2021 Oct 22, 2021	BUY	$13.71 - $17.18 $155,375 - $194,700	11,333 New	11,333 $161,000

118

64.2M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $423M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Spire Wealth Management with notifications on news.